AilsynBio is an AI-driven biotech company focused on developing next-generation orally available cyclic peptide therapeutics. Our proprietary AI platform integrates advanced molecular modeling, medicinal chemistry, and biology to rapidly design and optimize cyclic peptides against challenging drug targets. The platform has been validated through collaborations with multiple pharmaceutical companies. Our multidisciplinary team brings expertise from multinational pharmaceutical companies and world-leading biotech companies specializing in cyclic peptides, alongside deep capabilities in AI research, medicinal chemistry, and biology. The team also has proven track records contributing to market-approved drugs. AilsynBio is building a scalable AI-first platform to unlock the full therapeutic potential of cyclic peptides for diseases with high unmet medical needs.

AilsynBio Limited

Org chart

Teams

Offices

AilsynBio Limited

Org chart

Teams

Offices

Related companies